The P2X7 purinergic receptor: a potential therapeutic target for lung cancer.
Qianqian LiXiaodi ZhuWei SongXiao-Xiang PengRonglan ZhaoPublished in: Journal of cancer research and clinical oncology (2020)
In summary, P2X7R is expected to become a potential target for the treatment of lung cancer, and more clinical research is needed in the future to explore the effectiveness of P2X7R antagonists as treatments.